awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33405318-317DF35A-25E4-48EA-89A2-FD0699AE4C75
Q33405318-317DF35A-25E4-48EA-89A2-FD0699AE4C75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405318-317DF35A-25E4-48EA-89A2-FD0699AE4C75
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies
P2860
Q33405318-317DF35A-25E4-48EA-89A2-FD0699AE4C75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405318-317DF35A-25E4-48EA-89A2-FD0699AE4C75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d6ab2f15998dc6e843b265970b3430d5fe703da
P2860
Phase II study of sunitinib in patients with metastatic urothelial cancer.